Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Nasdaq

Plug Power Inc (NASDAQ:PLUG) has secured an order to deliver one gigawatt (GW) electrolyzer to hydrogen company H2 Energy Europe. The financial terms were not disclosed. The company noted that this is the world's largest capacity electrolyzer installation, planned for green hydrogen manufacturing plant in Denmark. Swiss-headquartered H2 Energy Europe is a JV…

Benzinga

Take-Two Analysts: Zynga Acquisition, Video Game Pipeline Highlight Future Growth

Video game company Take-Two Interactive Software (NASDAQ: TTWO) reported fiscal fourth-quarter financial results Monday. Analysts weighed in with their thoughts on the report and the pipeline of games ahead.

Benzinga

Why Tarena Shares Are Gaining Today

Tarena International Inc (NASDAQ:TEDU) reported first-quarter FY22 sales growth of 16.8% year-on-year, to $98.4 million, beating the consensus of $58.85 million. Revenue from childhood & adolescent quality education business increased 27.2% Y/Y, and adult professional education businesses climbed 5.5%. The gross profit increased 43.6% Y/Y to $56.6 million, and the margin expanded 1,080…

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Here's What To Watch On Twitter Stock As Elon Musk's Stake Goes Red

Twitter, Inc (NYSE: TWTR) was spiking up over 3% on Tuesday after falling almost 28% beginning on May 5 to reach a $36.85 low, putting Tesla, Inc (NASDAQ: TSLA) CEO Elon Musk in the red on the 9.2%

Benzinga

Elon Musk Says US Is Already In A Recession, Could Last Up To 18 Months Before 'Boom Time Again'

Tesla Inc (NASDAQ: TSLA) CEO Elon Musk said Monday the U.S. is probably in a recession— and added that it could get worse and last up to a year-and-a-half.

Benzinga

Summer Infant Q1 Sales Drop 5% On Supply Chain Issues

Summer Infant Inc (NASDAQ:SUMR) reported a first-quarter FY22 sales decline of 5% year-on-year to $34.38 million, versus $36.20 million the previous year. The company attributed the revenue decline to ongoing supply chain disruptions, including some COVID-19 caused production delays. The gross profit decreased 31.8% Y/Y to $7.3 million and the profit margin contracted…

Benzinga

InMed Pharmaceuticals Is Commercializing The Development Of Rare Cannabinoids For The Wellness Market

Upon its acquisition of BayMedica LLC last year, InMed Pharmaceuticals Inc. (Nasdaq: INM) made the executive decision to forge a new path alongside its traditional domain in pharmaceutical drug development.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

5 Hot Stocks Up 10%: What Other Companies Joined Coinbase On The List?

Benzinga’s “5 Stocks Up 10%” aims to deliver investors the news surrounding hot stocks with significant price action on May 17, 2022. The information provided for these hot stocks is compiled using the Movers and News tools in Benzinga Pro.

Benzinga

GrowGeneration Launches New Liquid Fertilizer For Commercial Cultivators

GrowGeneration Corp (NASDAQ:GRWG) has launched Drip Hydro, a fertilizer blend designed for commercial cultivators. Drip Hydro was developed by Rex Gill, founder of Power Si, the patented formula of mono-silicic acid for crops, along with Robert Masterson, the former owner of The Harvest Company. Drip Hydro is a liquid nutrient line that consists…

Benzinga

Q1 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolios

The latest round of 13F filings from institutional investors is out, revealing to the world the stocks that some of the richest and most successful investors have been buying and selling.

Benzinga

6 Stocks Moved By Traders On 'Fast Money: Halftime Report'

CNBC’s "Fast Money: Halftime Report" delivers market-moving news to investors.

Benzinga

Analyst Ratings for IGM Biosciences

IGM Biosciences (NASDAQ:IGMS) has observed the following analyst ratings within the last quarter:

Benzinga

Here's How Much $1000 Invested In Moderna 5 Years Ago Would Be Worth Today

Moderna (NASDAQ:MRNA) has outperformed the market over the past 5 years by 105.44% on an annualized basis producing an average annual return of 116.6%. Currently, Moderna has a market capitalization of $56.68 billion.

Benzinga

Morgan Stanley Cuts Rivian Price Target: EV Maker Needs To Restore Confidence It Can Be 'The One' To Challenge Tesla

Rivian Automotive Inc (NASDAQ: RIVN) is facing a new reality after its blockbuster listing last year and needs to ‘pace itself’ in the near term to be able to reinforce confidence that it has the potential to be "the one" that can challenge Tesla Inc (NASDAQ:

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Starbucks And 2 Other Stocks Insiders Are Buying

Although the Nasdaq Composite dropped 1.2% on Monday, there were a few notable insider trades.

Benzinga

Shareholders Rejected Intel's Top Executive Compensation Just A Month After It Painted Dismal Q2 Outlook

Intel Corp (NASDAQ:INTC) shareholders rejected compensation packages for top executives, including a payout of as much as $178.6 million to CEO Pat Gelsinger. Shareholders cast 1.78 billion votes against executive compensation at the annual meeting. Shareholders cast 921.2 million votes in favor of the compensation. The vote is non-binding. Gelsinger has earned 1,711 times as…

Benzinga

Why United Airlines Shares Are Trading Higher Today

United Airlines Holdings, Inc. (NASDAQ:UAL) updated its financial outlook for second-quarter 2022. The company stated that the demand environment has continued to improve following the previous guidance, resulting in a higher unit revenue outlook for Q2. Meanwhile, UAL noted that oil price has also increased, resulting in a higher expected fuel price for…

Benzinga

Aytu BioPharma Plans To Divest / Discontinue Non Core Assets

Aytu BioPharma Inc (NASDAQ:AYTU) will divest or discontinue non-core, unprofitable products, including Cefaclor, Flexichamber, Tuzistra XR, generic Tussionex, and Zolpimist. Aytu expects to improve gross margins for its ADHD product franchise by transferring manufacturing to a well-established, global commercial manufacturing organization, a transition expected to occur in mid-2023. Aytu is commercializing two novel…

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Bearish Bets On Twitter Follow Musk's Comments On Spam Accounts

Tesla Inc (NASDAQ: TSLA) CEO Elon Musk on Monday hinted at the possibility of paying less than his bid of $44 billion for Twitter Inc (NYSE: TWTR).

Benzinga

Apple Unveils New Feature To Simplify Podcast Distribution

Apple, Inc. (NASDAQ: AAPL) has announced a new feature that makes it easier for podcasters to get their premium audio on the tech giant's platform.

Benzinga

Google's Pixel Watch Is Reportedly Using Outdated Chip

Google, a subsidiary of Alphabet Inc (NASDAQ: GOOGL) (NASDAQ: GOOG), said recently it is coming out with the Pixel Watch this fall but now details have emerged that the wearable is underpinned by a four-year-old proces

Benzinga

Applied Genetic's Vision Loss Gene Therapy Shows Encouraging Safety, Efficacy At Three Months

Applied Genetic Technologies Corp (NASDAQ:AGTC) reported three-month interim data from its ongoing Phase 2 Skyline trial of AGTC-501 for X-linked retinitis pigmentosa (XLRP), an inherited condition causing progressive vision loss in boys and young men. AGTC-501 is a recombinant AAV viral vector-based gene therapy targeting mutations in the RPGR gene. There were robust…

Benzinga

24 Stocks Moving in Tuesday's Pre-Market Session

Gainers Bird Global, Inc. (NASDAQ: BRDS) rose 26.3% to $1.24 in pre-market trading after the company posted strong Q1 sales.

Benzinga

A Peek Into The Markets: US Stock Futures Higher Ahead Of Walmart Earnings

Pre-open movers

Benzinga

Analyst Says Sam Bankman-Fried's Robinhood Stake Signals 'Strong Support'

FTX founder and CEO Sam Bankman-Fried’s 7.6% position in Robinhood Markets Inc (NASDAQ: HOOD) is a signal of “strong support” for the trading platform popular with retail traders, according to Ar

1 … 468 469 470 471

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.